MACKENZIE SCHUMANN: Open Payments
NPI 1063033900 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 39 payments from 12 companies in 2025. Trend: 2023 $2,432 · 2024 $808 · 2025 $963
Food & beverage: $868Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $384 |
| Janssen Biotech, Inc. | 4 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| E.R. Squibb & Sons, L.L.C. | 2 | $91 |
| UCB, Inc. | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $39 |
| Amgen Inc. | 2 | $39 |
| Organon LLC | 4 | $35 |
| GENZYME CORPORATION | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: SKYRIZI, TREMFYA, RINVOQ, COSENTYX, Sotyktu, DUPIXENT, Bimzelx, OTEZLA.
Industry payments across WA — which companies pay providers there.
